Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
RESEARCH TOOLSreports
Amylyx Pharmaceuticals Inc (AMLX) Ownership - Who Owns Amylyx Pharmaceuticals Inc?
459 Followers
Amylyx Pharmaceuticals Inc (AMLX) Ownership Overview
46.06% Insiders
21.70% Mutual Funds
8.81% Other Institutional Investors
23.43% Public Companies and
Individual Investors
The ownership structure of Amylyx Pharmaceuticals Inc (AMLX) stock is a mix of institutional, retail and individual investors. Approximately 30.52% of the company’s stock is owned by Institutional Investors, 46.06% is owned by Insiders and 23.43% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 16, 2024 | Daphne Quimi Director | xxxxxxxxxxxxx | $9400 |
| Mar 07, 2024 | xxxxxxxxxxxxx | $28829 | |
| Mar 07, 2024 | Justin B. Klee Co Ceo,director | xxxxxxxxxxxxx | $77407 |
| Mar 07, 2024 | Joshua B Cohen Co Ceo,director | xxxxxxxxxxxxx | $77407 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $28400 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $852000 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1487512 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1489940 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,628,911 | Institution | 6.81% | 9,350,400 | |
| 3,575,216 | Institution | 5.26% | 7,221,936 | |
| 2,962,555 | Institution | 4.36% | 5,984,361 | |
| 1,267,837 | Institution | 1.86% | 2,561,031 | |
| 1,150,221 | Institution | 1.69% | 2,323,446 | |
| 936,967 | Institution | 1.38% | 1,892,673 | |
| 846,240 | Institution | 1.24% | 1,709,405 | |
| 831,462 | Institution | 1.22% | 1,679,553 | |
| 798,211 | Institution | 1.17% | 1,612,386 | |
| 786,000 | Institution | 1.16% | 1,587,720 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,628,911 | Institution | 6.81% | 9,350,400 | |
| 1,267,837 | Institution | 1.86% | 2,561,031 | |
| 831,462 | Institution | 1.22% | 1,679,553 | |
| 594,415 | Institution | 0.87% | 1,200,718 | |
| 578,710 | Institution | 0.85% | 1,168,994 | |
| 572,045 | Institution | 0.84% | 1,155,531 | |
| 537,478 | Institution | 0.79% | 1,085,706 | |
| 503,510 | Institution | 0.74% | 1,017,090 | |
| 446,592 | Institution | 0.66% | 902,116 | |
| 430,997 | Institution | 0.63% | 870,614 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,811,143 | Institution | 2.66% | 3,441,172 | |
| 642,775 | Institution | 0.95% | 1,221,273 | |
| 600,395 | Institution | 0.88% | 1,140,751 | |
| 387,802 | Institution | 0.57% | 710,585 | |
| 360,931 | Institution | 0.53% | 685,769 | |
| 339,031 | Institution | 0.50% | 684,843 | |
| 242,301 | Institution | 0.36% | 484,602 | |
| 191,413 | Institution | 0.28% | 382,826 | |
| 183,055 | Institution | 0.27% | 366,110 | |
| 183,055 | Institution | 0.27% | 366,110 |
FAQ
Who Owns Amylyx Pharmaceuticals Inc (AMLX)?
According to the latest TipRanks data, approximately 8.81% of the company's stock is held by institutional investors, 46.06% is held by insiders, and 23.43% is held by retail investors.
What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 8.81% of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors.
What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.43% of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors.
Who owns the most shares of Amylyx Pharmaceuticals Inc (AMLX)?
VANGUARD INDEX FUNDS owns the most shares of Amylyx Pharmaceuticals Inc (AMLX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.